RhoB Is Dispensable for Mouse Development, but It Modifies Susceptibility to Tumor Formation as Well as Cell Adhesion and Growth Factor Signaling in Transformed Cells

REFERENCES

• Adamson, P., H. F. Paterson, and A. Hall. 1992. Intracellular localization of the p21rho proteins. J. Cell Biol. 119:617–627.
   PubMed Web of Science ®Google Scholar
• Bizub, D., A. W. Wood, and A. M. Skalka. 1986. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc. Natl. Acad. Sci. USA 83:6048–6052.
   PubMed Web of Science ®Google Scholar
• Du, W., P. F. Lebowitz, and G. C. Prendergast. 1999. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol. Cell. Biol. 19:1831–1840.
   PubMed Web of Science ®Google Scholar
• Du, W., and G. C. Prendergast. 1999. Geranylgeranylated RhoB mediates inhibition of human tumor cell growth by farnesyltransferase inhibitors. Cancer Res. 59:5924–5928.
   Google Scholar
• Engel, M. E., P. K. Datta, and H. L. Moses. 1998. RhoB is stabilized by transforming growth factor β and antagonizes transcriptional activation. J. Biol. Chem. 273:9921–9926.
   PubMedGoogle Scholar
• Fritz, G., and B. Kaina. 2000. Ras-related GTPase RhoB forces alkylation-induced apoptotic cell death. Biochem. Biophys. Res. Commun. 268:784–789.
   PubMed Web of Science ®Google Scholar
• Fritz, G., and B. Kaina. 1997. rhoB encoding a UV-inducible ras-related small GTP-binding protein is regulated by GTPases of the rho family and independent of JNK, ERK, and p38 MAP kinase. J. Biol. Chem. 272:30637–30644.
   PubMedGoogle Scholar
• Fritz, G., B. Kaina, and K. Aktories. 1995. The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J. Biol. Chem. 270:25172–25177.
   PubMed Web of Science ®Google Scholar
• Gampel, A., P. J. Parker, and H. Mellor. 1999. Regulation of epidermal growth factor receptor traffic by the small GTPase RhoB. Curr. Biol. 9:955–958.
   PubMedGoogle Scholar
• Ise, K., K. Nakamura, K. Nakao, S. Shimizu, H. Harada, T. Ichise, J. Miyoshi, Y. Gondo, T. Ishikawa, A. Aiba, and M. Katsuki. 2000. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19:2151–2156.
   Google Scholar
• Jähner, D., and T. Hunter. 1991. The ras-related gene rhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11:3682–3690.
   PubMed Web of Science ®Google Scholar
• Jahner, D., and T. Hunter. 1991. The stimulation of quiescent rat fibroblasts by v-src and v-fps oncogenic protein-tyrosine kinases leads to the induction of a subset of immediate early genes. Oncogene 6:1259–1268.
   PubMed Web of Science ®Google Scholar
• Khosravi-Far, R., P. A. Solski, G. J. Clark, M. S. Kinch, and C. J. Der. 1995. Activation of Rac1, RhoA, and mitogen-activated protein kinase is required for Ras transformation. Mol. Cell. Biol. 15:6443–6453.
   PubMed Web of Science ®Google Scholar
• Lebowitz, P., P. J. Casey, G. C. Prendergast, and J. Thissen. 1997. Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. J. Biol. Chem. 272:15591–15594.
   PubMed Web of Science ®Google Scholar
• Lebowitz, P., and G. C. Prendergast. 1998. Functional interaction between RhoB and the transcription factor DB1. Cell Adhes. Commun. 6:277–287.
   PubMed Web of Science ®Google Scholar
• Lebowitz, P. F., D. Sakamuro, and G. C. Prendergast. 1997. Farnesyltransferase inhibitors induce apoptosis in Ras-transformed cells denied substratum attachment. Cancer Res. 57:708–713.
   PubMed Web of Science ®Google Scholar
• Liu, A.-X., W. Du, J.-P. Liu, T. M. Jessell, and G. C. Prendergast. 2000. RhoB alteration is necessary for the apoptotic and antineoplastic responses to farnesyltransferase inhibitors. Mol. Cell. Biol. 20:6105–6113.
   PubMed Web of Science ®Google Scholar
• Liu, J. P., and T. M. Jessell. 1998. A role for rhoB in the delamination of neural crest cells from the dorsal neural tube. Development 125:5055–5067.
   PubMedGoogle Scholar
• Mendrysa, S. M., and M. E. Perry. 2000. The p53 tumor suppressor protein does not regulate expression of its own inhibitor, MDM2, except under conditions of stress. Mol. Cell. Biol. 20:2023–2030.
   PubMedGoogle Scholar
• Michaelson, D., J. Silletti, G. Murphy, P. D'Eustachio, M. Rush, and M. R. Philips. 2001. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152:111–126.
   PubMed Web of Science ®Google Scholar
• Moustakas, A., and C. Stournaras. 1999. Regulation of actin organisation by TGF-beta in H-ras-transformed fibroblasts. J. Cell Sci. 112:1169–1179.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., J. P. Davide, S. J. deSolms, E. A. Giuliani, S. L. Graham, J. B. Gibbs, A. Oliff, and N. E. Kohl. 1994. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol. Cell. Biol. 14:4193–4202.
   PubMed Web of Science ®Google Scholar
• Prendergast, G. C., R. Khosravi-Far, P. Solski, H. Kurzawa, P. Lebowitz, and C. J. Der. 1995. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10:2289–2296.
   PubMed Web of Science ®Google Scholar
• Qiu, R. G., J. Chen, F. McCormick, and M. Symons. 1995. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781–11785.
   PubMed Web of Science ®Google Scholar
• Quintanilla, M., K. Brown, M. Ramsden, and A. Balmain. 1986. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78–80.
   PubMed Web of Science ®Google Scholar
• Zalcman, G., V. Closson, G. Linares-Cruz, F. Leregours, N. Honore, A. Tavitian, and B. Olofsson. 1995. Regulation of Ras-related RhoB protein expression during the cell cycle. Oncogene 10:1935–1945.
   PubMed Web of Science ®Google Scholar
• Zarbl, H., S. Sukumar, A. V. Arthur, D. Martin-Zanca, and M. Barbacid. 1985. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315:382–385.
   PubMed Web of Science ®Google Scholar